---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-25-000028"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2025-01-17T23:59:59+00:00"
generated_at: "2026-05-27T22:55:04.069387+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lifecore to hold special meeting April 10 to remove Series A preferred conversion cap

## Summary
- Special meeting on April 10, 2025 to vote on removing the 19.99% conversion cap on Series A Convertible Preferred Stock.
- If approved, up to 6,056,284 common shares could be issued upon conversion at the current conversion price.
- No holders have elected to convert as of Jan 17, 2025; company has no plans to raise additional equity capital.
- Board sets record date of Feb 18, 2025 for voting eligibility.
- Proposal needed to comply with Nasdaq Listing Rule 5635(d) regarding issuance over 19.99% of outstanding common.

## SEC filing metadata
- accession: 0001005286-25-000028
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2025-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000028/0001005286-25-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000028/lndc-20250117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-25-000028
- JSON: https://secwatch.observer/filing/0001005286-25-000028.json
- Plain text: https://secwatch.observer/filing/0001005286-25-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.